
The metabolic aberrations in patients with polycystic ovary syndrome (PCOS) demand a shift in clinical care from symptom driven to the prevention of chronic disease. The onset of carbohydrate intolerance or diabetes may be accelerated. The lipoprotein lipid profiles are compatible with the effects of insulin resistance. Disturbed cholesterol and triglyceride metabolism may eventuate in premature cardiovascular disease.

